Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Exosomes: a new perspective in EGFR-mutated lung cancer.
Cancer Metastasis Rev. 2021 Jun;40(2):589-601. doi: 10.1007/s10555-021-09962-6. Epub 2021 Apr 14.
Cancer Metastasis Rev. 2021.
PMID: 33855679
Free PMC article.
Review.
Updated Prevalence of Lymphangioleiomyomatosis in Europe.
Lynn E, Forde SH, Franciosi AN, Bendstrup E, Veltkamp M, Wind AE, Van Moorsel CHM, Lund TK, Durheim MT, Peeters EFHI, Keane MP, McCarthy C; and Northern European LAM Prevalence Consortium.
Lynn E, et al.
Am J Respir Crit Care Med. 2024 Feb 15;209(4):456-459. doi: 10.1164/rccm.202310-1736LE.
Am J Respir Crit Care Med. 2024.
PMID: 38060201
No abstract available.
Item in Clipboard
Transcriptomics and proteomics revealed sex differences in human pulmonary microvascular endothelial cells.
Kostyunina DS, Pakhomov NV, Jouida A, Dillon E, Baugh JA, McLoughlin P.
Kostyunina DS, et al. Among authors: jouida a.
Physiol Genomics. 2024 Feb 1;56(2):194-220. doi: 10.1152/physiolgenomics.00051.2023. Epub 2023 Dec 4.
Physiol Genomics. 2024.
PMID: 38047313
Item in Clipboard
Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion.
Jouida A, O'Callaghan M, Mc Carthy C, Fabre A, Nadarajan P, Keane MP.
Jouida A, et al.
Cancers (Basel). 2022 Aug 3;14(15):3776. doi: 10.3390/cancers14153776.
Cancers (Basel). 2022.
PMID: 35954442
Free PMC article.
Item in Clipboard
FHITlow /pHER2high signature in non-small cell lung cancer is predictive of anti-HER2 molecule efficacy.
Da Silva J, Jouida A, Ancel J, Dalstein V, Routhier J, Delepine G, Cutrona J, Jonquet A, Dewolf M, Birembaut P, Deslée G, Polette M, Nawrocki-Raby B.
Da Silva J, et al. Among authors: jouida a.
J Pathol. 2020 Jun;251(2):187-199. doi: 10.1002/path.5439. Epub 2020 May 13.
J Pathol. 2020.
PMID: 32237123
Free article.
Item in Clipboard
Cite
Cite